Association Between Mental Health Disorders and Mortality Among Patients With COVID-19 in 7 Countries
Open Access
- 1 November 2021
- journal article
- review article
- Published by American Medical Association (AMA) in JAMA Psychiatry
- Vol. 78 (11), 1208-1217
- https://doi.org/10.1001/jamapsychiatry.2021.2274
Abstract
More than 100 million people have been infected with SARS-CoV-2, and almost 2.5 million have died of COVID-19 worldwide.1 These numbers probably underestimate COVID-19 deaths by 50% owing to misclassified dementia and cardiovascular or metabolic deaths.2 Patients with mental health disorders may be at particular risk of poor COVID-19 outcomes. Patients with mental health disorders can have multiple comorbidities that have been identified as risk factors for severe COVID-19: diabetes, hypertension, chronic obstructive respiratory disease, and end-stage kidney disease.3 Mental health disorders are also associated with socioeconomic deprivation4 and reduced access to care,5 2 important factors of poor COVID-19 outcomes.6Keywords
This publication has 59 references indexed in Scilit:
- Advance directives in mental health care: evidence, challenges and promiseWorld Psychiatry, 2015
- Promoting physical health for people with schizophrenia by reducing disparities in medical and dental careActa Psychiatrica Scandinavica, 2015
- Serum Vitamin D Levels in Relation to Schizophrenia: A Systematic Review and Meta-Analysis of Observational StudiesJournal of Clinical Endocrinology & Metabolism, 2014
- Effects of Antipsychotics on the Inflammatory Response System of Patients with Schizophrenia in Peripheral Blood Mononuclear Cell CulturesClinical Psychopharmacology and Neuroscience, 2013
- Vitamin D deficiency and depression in adults: systematic review and meta-analysisThe British Journal of Psychiatry, 2013
- Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual levelWorld Psychiatry, 2011
- Common polygenic variation contributes to risk of schizophrenia and bipolar disorderNature, 2009
- Measuring inconsistency in meta-analysesBMJ, 2003
- Microbial Infections, Immunomodulation, and Drugs of AbuseClinical Microbiology Reviews, 2003